» Articles » PMID: 26811407

Clinicopathological Predictive Factors in the Early Remission of Corticotroph Pituitary Macroadenomas in a Tertiary Referral Centre

Overview
Specialty Endocrinology
Date 2016 Jan 27
PMID 26811407
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Corticotroph macroadenomas are a rare cause of Cushing's disease (CD), but their properties are not well-recognised. The aim of this study was to evaluate the clinical and pathological aspects of corticotroph macroadenomas with particular emphasis on proliferation markers and their associations with the efficacy of surgical treatment.

Design: A prospective cohort study was conducted in a tertiary referral centre in Poland.

Methods: In total, 59 patients with CD (20 macroadenomas and 39 microadenomas) were included in this study. Hormonal and imaging parameters, histopathological and ultrastructural features of the corticotroph tumours and the early surgical outcomes were evaluated.

Results: ACTH and ACTH/cortisol ratios were higher in macroadenomas (P<0.001 and P=0.002 respectively). Greater tumour volumes were associated with higher Ki-67 and p53 expression (Ptrend=0.009 and Ptrend=0.024 respectively) and the rates of sparsely granulated adenomas (Ptrend=0.036). Immediate postoperative remission and early biochemical remission rates were lower in macroadenomas compared to microadenomas (P<0.001). A logistic regression model showed that the immediate postoperative remission or early biochemical remission depended on tumour volume (P=0.005 and P=0.006 respectively) and invasiveness based on Knosp grades 3 and 4 for macroadenomas and a lack of surgical pseudocapsule for microadenomas (P=0.004 and P=0.007 respectively).

Conclusion: Corticotroph macroadenomas differ from the more common microadenomas not only in terms of hormonal and imaging characteristics but also in terms of immunohistochemical and ultrastructural features and proliferation markers. The early effectiveness of surgery depends primarily on tumour volume and invasiveness.

Citing Articles

Granulation Patterns of Functional Corticotroph Tumors Correlate with Tumor Size, Proliferative Activity, T2 Intensity-to-White Matter Ratio, and Postsurgical Early Biochemical Remission.

Durmus E, Kefeli M, Mete O, Caliskan S, Aslan K, Onar M Endocr Pathol. 2024; 35(3):185-193.

PMID: 39046680 PMC: 11387444. DOI: 10.1007/s12022-024-09819-y.


Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing's disease.

Stroud A, Dhaliwal P, Harvey R, Alvarado R, Jonker B, Winder M Endocr Oncol. 2023; 2(1):19-31.

PMID: 37435446 PMC: 10259300. DOI: 10.1530/EO-21-0026.


Double Pituitary Adenomas in Patients With Cushing's Disease.

Voznyak O, Hryniv N, Lytvynenko A, Zinkevych Y Cureus. 2023; 15(5):e38923.

PMID: 37188065 PMC: 10176272. DOI: 10.7759/cureus.38923.


Sparsely Granulated Corticotroph Pituitary Macroadenoma Presenting With Pituitary Apoplexy Resulting in Remission of Hypercortisolism.

Liu T, Rossiter J, Houlden R, Awad S AACE Clin Case Rep. 2022; 8(4):166-170.

PMID: 35959088 PMC: 9363514. DOI: 10.1016/j.aace.2022.04.003.


Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing's Disease: Does Size Matter?.

Akirov A, Shimon I, Fleseriu M, Dotan I, Manisterski Y, Aviran-Barak N J Clin Med. 2022; 11(6).

PMID: 35329884 PMC: 8953359. DOI: 10.3390/jcm11061558.


References
1.
Knosp E, Steiner E, Kitz K, Matula C . Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993; 33(4):610-7; discussion 617-8. DOI: 10.1227/00006123-199310000-00008. View

2.
Miermeister C, Petersenn S, Buchfelder M, Fahlbusch R, Ludecke D, Holsken A . Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications. Acta Neuropathol Commun. 2015; 3:50. PMC: 4545559. DOI: 10.1186/s40478-015-0229-8. View

3.
Thapar K, Scheithauer B, Kovacs K, Pernicone P, Laws Jr E . p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery. 1996; 38(4):765-70; discussion 770-1. View

4.
Blevins Jr L, Christy J, Khajavi M, TINDALL G . Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab. 1998; 83(1):63-7. DOI: 10.1210/jcem.83.1.4525. View

5.
Losa M, Barzaghi R, Mortini P, Franzin A, Mangili F, Terreni M . Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas. Am J Pathol. 2000; 156(1):245-51. PMC: 1868637. DOI: 10.1016/S0002-9440(10)64725-6. View